Literature DB >> 21283092

2010 FDA drug approvals.

Asher Mullard.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21283092     DOI： 10.1038/nrd3370

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  18 in total

Review 1.  Microfabrication technologies for oral drug delivery.

Authors:  Shilpa Sant; Sarah L Tao; Omar Z Fisher; Qiaobing Xu; Nicholas A Peppas; Ali Khademhosseini
Journal:  Adv Drug Deliv Rev       Date:  2011-12-04       Impact factor: 15.470

2.  The mass-action law based algorithm for cost-effective approach for cancer drug discovery and development.

Authors:  Ting-Chao Chou
Journal:  Am J Cancer Res       Date:  2011-08-05       Impact factor: 6.166

Review 3.  Tetracyclines and pain.

Authors:  Leandro F S Bastos; Antônio C P de Oliveira; Linda R Watkins; Márcio F D Moraes; Márcio M Coelho
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-01-27       Impact factor: 3.000

Review 4.  Protein particulate detection issues in biotherapeutics development--current status.

Authors:  Tapan K Das
Journal:  AAPS PharmSciTech       Date:  2012-05-08       Impact factor: 3.246

Review 5.  High-throughput biophysical analysis of protein therapeutics to examine interrelationships between aggregate formation and conformational stability.

Authors:  Rajoshi Chaudhuri; Yuan Cheng; C Russell Middaugh; David B Volkin
Journal:  AAPS J       Date:  2013-10-31       Impact factor: 4.009

6.  Challenges and opportunities in the design of age-appropriate drug products.

Authors:  S Stegemann
Journal:  Z Gerontol Geriatr       Date:  2012-08       Impact factor: 1.281

Review 7.  Self-assembling peptide-based building blocks in medical applications.

Authors:  Handan Acar; Samanvaya Srivastava; Eun Ji Chung; Mathew R Schnorenberg; John C Barrett; James L LaBelle; Matthew Tirrell
Journal:  Adv Drug Deliv Rev       Date:  2016-08-14       Impact factor: 15.470

8.  Rituximab for non-Hodgkin's lymphoma: a story of rapid success in translation.

Authors:  Andrew M Harrison; Nassir M Thalji; Alexandra J Greenberg; Carmen J Tapia; Anthony J Windebank
Journal:  Clin Transl Sci       Date:  2013-10-03       Impact factor: 4.689

Review 9.  Modeling, simulation, and translation framework for the preclinical development of monoclonal antibodies.

Authors:  Kenneth T Luu; Eugenia Kraynov; Bing Kuang; Paolo Vicini; Wei-Zhu Zhong
Journal:  AAPS J       Date:  2013-02-14       Impact factor: 4.009

10.  Unraveling the autoimmune translational research process layer by layer.

Authors:  Richard S Blumberg; Bonnie Dittel; David Hafler; Matthias von Herrath; Frank O Nestle
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.